CD274 and neoplasm: Recent research found that manganese oxide nanomaterials as an oxygen supplier could reduce PD-L1 expression by overcoming tumor hypoxia [68], which also provided a possible mechanism and notion for the triple treatment with PD-1/PD-L1 inhibitor.